NCT05888467 Physical Activity and Cardiovascular Profile of Pre-conceptional Women At Risk for GHD
| NCT ID | NCT05888467 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Hasselt University |
| Condition | Gestational Hypertension |
| Study Type | INTERVENTIONAL |
| Enrollment | 140 participants |
| Start Date | 2023-05-15 |
| Primary Completion | 2025-08 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 140 participants in total. It began in 2023-05-15 with a primary completion date of 2025-08.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
To compare the cardiovascular profile of pre-conceptional women at risk for developing Gestational Hypertensive Disorders in subsequent pregnancy before and after physical activity.
Eligibility Criteria
Inclusion Criteria: * Women at risk for the development of GHD in subsequent pregnancy based on the presence of at least one of the following risk factors: * high body mass index (BMI\>30 kg/m²) * a family history of PE (mother, sister) * in the need of assisted reproduction techniques in a previous or subsequent pregnancy * maternal comorbidities: prior PE, diabetes mellitus, chronic hypertension, chronic kidney disease or antiphospholipid syndrome * Non-pregnant (as confirmed by a negative pregnancy urine dipstick test) * Age ≥ 18 years * Being able to understand the Dutch language Exclusion Criteria: Participants eligible for this study must not meet any of the following criteria: * Pregnant at inclusion * Not being able to exercise according to physician's decision * Suffering from underlying diseases that can affect the CV profile such as oncological diseases coronary heart disease, aortic disease, peripheral arterial disease * Participating in another clinical study that may alter the results of this study
Contact & Investigator
Dorien Lanssens
PRINCIPAL INVESTIGATOR
UHasselt
Frequently Asked Questions
Who can join the NCT05888467 clinical trial?
This trial is open to female participants only, aged 18 Years or older, up to 50 Years, studying Gestational Hypertension. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05888467 currently recruiting?
Yes, NCT05888467 is actively recruiting participants. Contact the research team at pauline.dreesen@uhasselt.be for enrollment information.
Where is the NCT05888467 trial being conducted?
This trial is being conducted at Diepenbeek, Belgium.
Who is sponsoring the NCT05888467 clinical trial?
NCT05888467 is sponsored by Hasselt University. The principal investigator is Dorien Lanssens at UHasselt. The trial plans to enroll 140 participants.